Stefan Chlopicki Selected Research

S961 peptide

1/2021

Systemic Administration of Insulin Receptor Antagonist Results in Endothelial and Perivascular Adipose Tissue Dysfunction in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan Chlopicki Research Topics

Disease

23	Inflammation (Inflammations) 05/2022 - 01/2014
20	Atherosclerosis 12/2021 - 02/2007
13	Neoplasms (Cancer) 01/2022 - 04/2015
11	Atherosclerotic Plaque (Atheroma) 11/2019 - 02/2007
9	Thrombosis (Thrombus) 01/2022 - 04/2004
9	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2016
9	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2016
9	Hypertension (High Blood Pressure) 12/2021 - 04/2015
8	Fatty Liver 01/2020 - 07/2014
8	Non-alcoholic Fatty Liver Disease 01/2019 - 01/2015
6	Cardiovascular Diseases (Cardiovascular Disease) 04/2020 - 08/2015
6	Heart Failure 01/2020 - 08/2008
5	Insulin Resistance 11/2021 - 02/2015
3	Obesity 10/2021 - 06/2017
3	Necrosis 01/2021 - 04/2015
3	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2014
3	Body Weight (Weight, Body) 06/2018 - 01/2010
2	Aortic Valve Disease 06/2021 - 02/2020
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2016
2	Hyperglycemia 01/2021 - 01/2008
2	Hypercholesterolemia 12/2020 - 01/2019
2	Cardiomegaly (Heart Hypertrophy) 01/2020 - 01/2020
2	Endotoxemia 01/2019 - 01/2018
2	Acute-Phase Reaction 01/2018 - 09/2015
2	Hepatitis 02/2016 - 09/2015
2	Pulmonary Hypertension 01/2016 - 04/2015
2	Pulmonary Arterial Hypertension 01/2016 - 04/2015
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 03/2013 - 08/2008
2	Hypertriglyceridemia 04/2010 - 01/2008
2	Infarction (Infarctions) 12/2006 - 04/2004
2	Myocardial Infarction 12/2006 - 04/2004

Drug/Important Bio-Agent (IBA)

24	LipidsIBA 01/2022 - 01/2008
18	Apolipoproteins E (ApoE)IBA 11/2021 - 02/2007
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2014
9	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 07/2015
8	CholesterolIBA 02/2020 - 02/2007
7	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 05/2022 - 10/2018
7	EnzymesIBA 06/2021 - 11/2016
6	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2015
6	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2021 - 01/2008
6	N(1)-methylnicotinamideIBA 01/2017 - 01/2008
5	Triglycerides (Triacylglycerol)IBA 02/2020 - 02/2007
5	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 02/2015
4	Thrombin FDA Link 01/2022 - 01/2019
4	LDL Receptors (LDL Receptor)IBA 11/2021 - 02/2007
4	ApolipoproteinsIBA 11/2021 - 02/2007
4	Angiotensin IIIBA 08/2021 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2015
4	Adenosine (Adenocard)FDA LinkGeneric 02/2020 - 01/2014
4	NucleotidesIBA 02/2020 - 01/2014
4	O(2)- vinyl- 1- (pyrrolidin- 1- yl)diazen- 1- ium- 1,2- diolateIBA 06/2018 - 02/2015
4	oil red OIBA 01/2016 - 02/2007
3	N-nitroso-N-methyltyramine (NNMT)IBA 10/2021 - 01/2016
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2019
3	NitritesIBA 01/2021 - 02/2016
3	NitratesIBA 01/2021 - 02/2016
3	Superoxides (Superoxide)IBA 01/2021 - 01/2018
3	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2020 - 01/2019
3	E-SelectinIBA 11/2020 - 01/2019
3	Plasminogen Activator Inhibitor 1IBA 11/2020 - 01/2019
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2020 - 01/2019
3	Angiopoietin-2IBA 11/2020 - 01/2019
3	Adenosine Triphosphate (ATP)IBA 02/2020 - 09/2015
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018 - 01/2017
3	AngiotensinsIBA 01/2018 - 01/2017
3	Concanavalin AIBA 12/2016 - 09/2015
3	FructoseIBA 01/2015 - 01/2008
2	Cholesterol Esters (Cholesteryl Esters)IBA 01/2022 - 12/2011
2	Dabigatran FDA Link 01/2022 - 08/2021
2	Adenine NucleotidesIBA 06/2021 - 11/2016
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2018
2	LipopolysaccharidesIBA 01/2021 - 01/2019
2	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 11/2020 - 01/2019
2	Syndecan-1 (Syndecan 1)IBA 11/2020 - 01/2019
2	EicosanoidsIBA 04/2020 - 01/2020
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2020 - 12/2018
2	NAD (NADH)IBA 01/2020 - 09/2015
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 04/2018
2	AnthracyclinesIBA 12/2019 - 04/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2019 - 04/2015
2	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2019 - 01/2019
2	Peptides (Polypeptides)IBA 03/2019 - 08/2015
2	Adenosine DeaminaseIBA 01/2019 - 11/2016
2	von Willebrand FactorIBA 01/2019 - 01/2018
2	CollagenIBA 01/2019 - 01/2018
2	FibrinIBA 01/2019 - 09/2012
2	Carbon MonoxideIBA 10/2018 - 09/2012
2	GlycogenIBA 04/2018 - 01/2015
2	Adenosine Diphosphate (ADP)IBA 01/2018 - 09/2015
2	Contrast MediaIBA 01/2018 - 12/2016
2	O2-vinyl 1- (2- (carboxylato)pyrrolidin- 1- yl)diazen- 1- ium- 1,2- diolateIBA 06/2017 - 07/2015
2	HaptoglobinsIBA 02/2016 - 09/2015
2	AcidsIBA 07/2015 - 04/2015
2	Conjugated Linoleic AcidsIBA 01/2015 - 01/2008
2	endothelium-dependent hyperpolarization factor (EDHF)IBA 08/2012 - 12/2006
2	Streptozocin (Streptozotocin)FDA Link 01/2010 - 01/2008

Therapy/Procedure

8	Therapeutics 01/2022 - 08/2015
2	Extracorporeal Circulation 10/2015 - 10/2009
2	Ligation 04/2015 - 12/2006
1	Intravenous Injections 01/2022